- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT06345729
프로그래밍된 세포 사멸 리간드 1(PD-L1) 종양 비율 점수(TPS)가 ≥50%인 KRAS G12C 돌연변이, 전이성 비소세포폐암(NSCLC) 참가자를 대상으로 한 MK-1084와 펨브롤리주맙(MK-3475)에 대한 연구 (MK-1084-004)
PD-L1 TPS가 50% 이상인 KRAS G12C 변이체, 전이성 NSCLC 참가자의 1차 치료제로서 펨브롤리주맙과 병용 MK-1084를 펨브롤리주맙과 위약과 비교한 3상, 무작위, 이중 맹검, 다기관 연구
This is a study evaluating the efficacy and safety of calderasib with pembrolizumab as first-line treatment in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) with identified Kirsten rat sarcoma viral oncogene homolog G12C (KRAS G12C) mutation and programmed cell death ligand 1 (PD-L1) tumor proportion score (TPS) ≥50%. There is one primary study hypothesis:
Combination of calderasib and pembrolizumab is superior to placebo plus pembrolizumab with respect to progression free survival (PFS) per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) by blinded independent central review (BICR).
연구 개요
상세 설명
Per Protocol Amendment 04, overall survival (OS) was moved to be a secondary outcome measure. Additionally, no new participants will be offered Second Course treatment for pembrolizumab.
연구 유형
등록 (추정된)
단계
- 3단계
연락처 및 위치
연구 연락처
- 이름: Toll Free Number
- 전화번호: 1-888-577-8839
- 이메일: Trialsites@msd.com
연구 장소
-
-
-
Tbilisi, 그루지야, 0112
- 모병
- Todua Clinic, LLC ( Site 1204)
-
연락하다:
- Study Coordinator
- 전화번호: +995322575757
-
Tbilisi, 그루지야, 0162
- 모병
- New Hospitals ( Site 1200)
-
연락하다:
- Study Coordinator
- 전화번호: +995 598 988 566
-
Tbilisi, 그루지야, 0177
- 모병
- Cancer Research Centre. Mardaleishvili Medical Centre ( Site 1205)
-
연락하다:
- Study Coordinator
- 전화번호: +995322430100
-
Tbilisi, 그루지야, 0102
- 모병
- American Hospital Network LLC ( Site 1208)
-
연락하다:
- Study Coordinator
- 전화번호: +995 571 300 705
-
Tbilisi, 그루지야, 1206
- 완전한
- Tbilisi Institute of Medicine ( Site 1206)
-
Tbilisi, 그루지야, 0144
- 완전한
- TSMU and Ingorokva High Medical Technology University Clinic LTD ( Site 1201)
-
Tbilisi, 그루지야, 0159
- 모병
- "Institute of Clinical Oncology" LTD ( Site 1210)
-
연락하다:
- Study Coordinator
- 전화번호: +995599406920
-
-
Adjara
-
Batumi, Adjara, 그루지야, 6000
- 모병
- High Technology Hospital Medcenter ( Site 1203)
-
연락하다:
- Study Coordinator
- 전화번호: +995596226060
-
Tbilisi, Adjara, 그루지야, 0186
- 모병
- Caucasus Medical Centre ( Site 1202)
-
연락하다:
- Study Coordinator
- 전화번호: +995 597 550 140
-
-
Imereti
-
Kutaisi, Imereti, 그루지야, 4600
- 모병
- JSC "Vian" ( Site 1211)
-
연락하다:
- Study Coordinator
- 전화번호: +995599705858
-
-
-
-
-
Thessaloniki, 그리스, 570 10
- 모병
- G. Papanikolaou General Hospital-Pulmonary Clinic of Aristotle University of Thessaloniki ( Site 1405)
-
연락하다:
- Study Coordinator
- 전화번호: 0030 231330787476
-
Thessaloniki, 그리스, 570 01
- 모병
- European Interbalkan Medical Center ( Site 1404)
-
연락하다:
- Study Coordinator
- 전화번호: +302310380000
-
-
Achaia
-
Pátrai, Achaia, 그리스, 26504
- 모병
- UNIVERSITY HOSPITAL OF PATRAS-DIVISION OF ONCOLOGY ( Site 1402)
-
연락하다:
- Study Coordinator
- 전화번호: +302610999791
-
-
Attica
-
Athens, Attica, 그리스, 115 27
- 모병
- THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA"-3rd Dept of Internal Medicine and Laboratory, Oncol ( Site 1400)
-
연락하다:
- Study Coordinator
- 전화번호: +302107700220
-
Athens, Attica, 그리스, 115 22
- 모병
- Agios Savvas Regional Cancer Hospital-2nd Medical Oncology Department ( Site 1407)
-
연락하다:
- Study Coordinator
- 전화번호: +302106409501
-
Marousi, Attica, 그리스, 151 25
- 모병
- Athens Medical Center ( Site 1406)
-
연락하다:
- Study Coordinator
- 전화번호: +302107464642
-
Piraeus, Attica, 그리스, 185 37
- 모병
- Metaxa Cancer Hospital of Piraeus ( Site 1408)
-
연락하다:
- Study Coordinator
- 전화번호: +302132079225
-
-
Thessaly
-
Larissa, Thessaly, 그리스, 411 10
- 모병
- University General Hospital of Larissa-Oncology Clinic ( Site 1403)
-
연락하다:
- Study Coordinator
- 전화번호: +302413502124
-
-
-
-
-
Utrecht, 네덜란드, 3584 CX
- 모병
- Universitair Medisch Centrum Utrecht ( Site 1704)
-
연락하다:
- Study Coordinator
- 전화번호: 00318875555555
-
-
Gelderland
-
Ede, Gelderland, 네덜란드, 6716 RP
- 모병
- Ziekenhuis Gelderse Vallei ( Site 1705)
-
연락하다:
- Study Coordinator
- 전화번호: 0318435499
-
Harderwijk, Gelderland, 네덜란드, 3844 DG
- 모병
- Ziekenhuis St. Jansdal-Poli Longziekten ( Site 1701)
-
연락하다:
- Study Coordinator
- 전화번호: 0031341463504
-
-
Overijssel
-
Hengelo, Overijssel, 네덜란드, 7555 DL
- 모병
- Ziekenhuisgroep Twente, locatie Almelo ( Site 1706)
-
연락하다:
- Study Coordinator
- 전화번호: +31887087878
-
Zwolle, Overijssel, 네덜란드, 8025 AB
- 모병
- Isala, locatie Zwolle-Poli Longziekten ( Site 1700)
-
연락하다:
- Study Coordinator
- 전화번호: 0031886243254
-
-
-
-
-
Auckland, 뉴질랜드, 1023
- 모병
- Auckland City Hospital ( Site 3400)
-
연락하다:
- Study Coordinator
- 전화번호: +6493074949
-
-
-
-
-
Incheon, 대한민국, 22332
- 모병
- Inha University Hospital ( Site 3610)
-
연락하다:
- Study Coordinator
- 전화번호: +82328901038
-
Seoul, 대한민국, 02447
- 모병
- Kyung Hee University Hospital ( Site 3605)
-
연락하다:
- Study Coordinator
- 전화번호: 82-2-958-8511
-
Seoul, 대한민국, 08308
- 모병
- Korea University Guro Hospital ( Site 3601)
-
연락하다:
- Study Coordinator
- 전화번호: +82226261914
-
Seoul, 대한민국, 03312
- 모병
- The Catholic University of Korea, Eunpyeong St. Mary's Hospital ( Site 3608)
-
연락하다:
- Study Coordinator
- 전화번호: +82220304340
-
Seoul, 대한민국, 02841
- 모병
- Korea University Anam Hospital ( Site 3609)
-
연락하다:
- Study Coordinator
- 전화번호: +8229206409
-
-
Incheon
-
Bupyeong-gu, Incheon, 대한민국, 21431
- 모병
- The Catholic University of Korea, Incheon St. Mary's Hospital ( Site 3606)
-
연락하다:
- Study Coordinator
- 전화번호: +82-32-280-6474
-
-
Jeonranamdo
-
Hwasun, Jeonranamdo, 대한민국, 58128
- 완전한
- Chonnam National University Hwasun Hospital-Pulmonology ( Site 3604)
-
-
Kyonggi-do
-
Suwon, Kyonggi-do, 대한민국, 16247
- 모병
- The Catholic University Of Korea St. Vincent's Hospital-Medical Oncology ( Site 3600)
-
연락하다:
- Study Coordinator
- 전화번호: 82-31-244-7983
-
-
Kyongsangnam-do
-
Yangsan, Kyongsangnam-do, 대한민국, 50612
- 모병
- Pusan National University Yangsan Hospital-Lung Cancer Clinic ( Site 3603)
-
연락하다:
- Study Coordinator
- 전화번호: +82-55-360-1415
-
-
Taegu-Kwangyokshi
-
Daegu, Taegu-Kwangyokshi, 대한민국, 42415
- 모병
- Yeungnam University Hospital ( Site 3607)
-
연락하다:
- Study Coordinator
- 전화번호: +82536203848
-
Daegu, Taegu-Kwangyokshi, 대한민국, 42601
- 모병
- Keimyung University Dongsan Hospital ( Site 3611)
-
연락하다:
- Study Coordinator
- 전화번호: +82532587737
-
-
Taejon-Kwangyokshi
-
Junggu, Taejon-Kwangyokshi, 대한민국, 35015
- 모병
- Chungnam national university hospital ( Site 3602)
-
연락하다:
- Study Coordinator
- 전화번호: 82-42-257-5753
-
-
-
-
Baden-Wurttemberg
-
Stuttgart, Baden-Wurttemberg, 독일, 70199
- 모병
- Marienhospital Stuttgart ( Site 1302)
-
연락하다:
- Study Coordinator
- 전화번호: +49711064893273
-
-
Mecklenburg-Vorpommern
-
Greifswald, Mecklenburg-Vorpommern, 독일, 17489
- 모병
- Universitätsmedizin Greifswald ( Site 1308)
-
연락하다:
- Study Coordinator
- 전화번호: +4938348622006
-
-
North Rhine-Westphalia
-
Bielefeld, North Rhine-Westphalia, 독일, 33611
- 모병
- Evangelisches Krankenhaus Bielefeld - Johannesstift ( Site 1307)
-
연락하다:
- Study Coordinator
- 전화번호: 0521 772 75504
-
Solingen, North Rhine-Westphalia, 독일, 42699
- 모병
- Krankenhaus Bethanien ( Site 1303)
-
연락하다:
- Study Coordinator
- 전화번호: +49212636661
-
-
-
-
-
Brasov, 루마니아, 500052
- 모병
- SC ONCO CARD SRL ( Site 1995)
-
연락하다:
- Study Coordinator
- 전화번호: +40268 994
-
Bucharest, 루마니아, 077190
- 모병
- SC MNT HEALTHCARE EUROPE SRL ( Site 1991)
-
연락하다:
- Study Coordinator
- 전화번호: +40722927377
-
Cluj-Napoca, 루마니아, 400015
- 모병
- Institutul Oncologic Cluj-Oncologie Medicala ( Site 1999)
-
연락하다:
- Study Coordinator
- 전화번호: +40264598362
-
Suceava, 루마니아, 720214
- 모병
- Sigmedical Services SRL ( Site 1997)
-
연락하다:
- Study Coordinator
- 전화번호: +4 0330 803 483
-
-
Bucharest
-
Bucharest, Bucharest, 루마니아, 020335
- 모병
- Centrul de Diagnostic si Tratament Provita. ( Site 1992)
-
연락하다:
- Study Coordinator
- 전화번호: +4021.9432
-
-
Dolj
-
Craiova, Dolj, 루마니아, 200542
- 모병
- Centrul de Oncologie Sfantul Nectarie-Medical ( Site 1994)
-
연락하다:
- Study Coordinator
- 전화번호: +40731604432
-
-
Timiș County
-
Timișoara, Timiș County, 루마니아, 300239
- 모병
- Cabinet Medical Oncomed ( Site 1998)
-
연락하다:
- Study Coordinator
- 전화번호: +40356460995
-
-
-
-
-
México, 멕시코, 14080
- 모병
- Instituto Nacional de Cancerologia. ( Site 0608)
-
연락하다:
- Study Coordinator
- 전화번호: +525556280400
-
Oaxaca City, 멕시코, 68000
- 모병
- Oaxaca Site Management Organization S.C. ( Site 0603)
-
연락하다:
- Study Coordinator
- 전화번호: +529515147056
-
-
Mexico City
-
Mexico City, Mexico City, 멕시코, 06700
- 모병
- Arké SMO S.A. de C.V. ( Site 0602)
-
연락하다:
- Study Coordinator
- 전화번호: 5533345856
-
-
Nuevo León
-
Monterrey, Nuevo León, 멕시코, 66460
- 모병
- Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Hematologia and Oncologia ( Site 0600)
-
연락하다:
- Study Coordinator
- 전화번호: +528180883663
-
-
-
-
California
-
Bakersfield, California, 미국, 93309
- 모병
- CBCC Global Research, Inc. ( Site 0123)
-
연락하다:
- Study Coordinator
- 전화번호: 661-322-2206
-
Beverly Hills, California, 미국, 90211
- 모병
- Beverly Hills Cancer Center ( Site 0116)
-
연락하다:
- Study Coordinator
- 전화번호: 310-432-8955
-
-
Connecticut
-
Stamford, Connecticut, 미국, 06902
- 모병
- Stamford Hospital ( Site 0136)
-
연락하다:
- Study Coordinator
- 전화번호: 877-233-9355
-
-
Florida
-
Miami Beach, Florida, 미국, 33140
- 완전한
- Mount Sinai Cancer Center ( Site 0137)
-
-
Illinois
-
Skokie, Illinois, 미국, 60077
- 모병
- Orchard Healthcare Research Inc. ( Site 0115)
-
연락하다:
- Study Coordinator
- 전화번호: 224-534-7580
-
-
Missouri
-
Kansas City, Missouri, 미국, 64108
- 모병
- Truman Medical Center ( Site 0126)
-
연락하다:
- Study Coordinator
- 전화번호: 816-404-4093
-
Springfield, Missouri, 미국, 65807
- 모병
- Cox Medical Center North ( Site 0133)
-
연락하다:
- Study Coordinator
- 전화번호: 417-875-3000
-
-
Montana
-
Billings, Montana, 미국, 59102
- 모병
- St. Vincent Frontier Cancer Center-Research ( Site 0105)
-
연락하다:
- Study Coordinator
- 전화번호: 402-238-6685
-
-
New Jersey
-
Morristown, New Jersey, 미국, 07960
- 완전한
- Atlantic Health System Morristown Medical Center ( Site 0121)
-
-
New York
-
Albany, New York, 미국, 12206
- 모병
- New York Oncology Hematology, P.C. ( Site 0132)
-
연락하다:
- Study Coordinator
- 전화번호: 518-489-3612
-
-
Ohio
-
Cincinnati, Ohio, 미국, 45219
- 모병
- University of Cincinnati Medical Center-University of Cincinnati Cancer Center ( Site 0103)
-
연락하다:
- Study Coordinator
- 전화번호: 513-556-6000
-
Kettering, Ohio, 미국, 45429
- 완전한
- Kettering Health Main Campus-Kettering Health Cancer Center ( Site 0106)
-
-
Pennsylvania
-
Lancaster, Pennsylvania, 미국, 17601
- 모병
- Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0134)
-
연락하다:
- Study Coordinator
- 전화번호: 717-544-9400
-
-
Texas
-
Houston, Texas, 미국, 77030
- 모병
- Oncology Consultants P.A. ( Site 0113)
-
연락하다:
- Study Coordinator
- 전화번호: 713-600-0900
-
-
Wisconsin
-
Madison, Wisconsin, 미국, 53715
- 모병
- Circuit Clinical/SSM Health Dean Medical Group ( Site 0129)
-
연락하다:
- Study Coordinator
- 전화번호: 608-410-2767
-
-
-
-
-
Pleven, 불가리아, 5804
- 모병
- MHAT - Heart and Brain ( Site 1006)
-
연락하다:
- Study Coordinator
- 전화번호: +35988030371
-
Plovdiv, 불가리아, 4000
- 모병
- Medical Center Futuremeds ( Site 1007)
-
연락하다:
- Study Coordinator
- 전화번호: +359886744494
-
Plovdiv, 불가리아, 4004
- 모병
- Complex Oncology Center - Plovdiv EOOD ( Site 1003)
-
연락하다:
- Study Coordinator
- 전화번호: +359 32 277 240
-
-
Pazardzhik
-
Panagyurishte, Pazardzhik, 불가리아, 4500
- 모병
- MBAL Uni Hospital-Department of Medical Oncology ( Site 1000)
-
연락하다:
- Study Coordinator
- 전화번호: +35935788581
-
-
Sofia (stolitsa)
-
Sofia, Sofia (stolitsa), 불가리아, 1632
- 모병
- Multiprofile Hospital for Active Treatment SerdikaМЕD EOOD-Second Department of Medical Oncology ( Site 1002)
-
연락하다:
- Study Coordinator
- 전화번호: +35929049100
-
-
-
-
-
Rio de Janeiro, 브라질, 22775-001
- 모병
- Americas ( Site 0431)
-
연락하다:
- Study Coordinator
- 전화번호: +552133852088
-
Rio de Janeiro, 브라질, 20230-130
- 모병
- Instituto Nacional de Câncer - INCA ( Site 0446)
-
연락하다:
- Study Coordinator
- 전화번호: +552132076564
-
-
Minas Gerais
-
Belo Horizonte, Minas Gerais, 브라질, 30380-472
- 모병
- Hospital Mario Penna ( Site 0436)
-
연락하다:
- Study Coordinator
- 전화번호: +553132999543
-
-
Pernambuco
-
Recife, Pernambuco, 브라질, 50040-000
- 모병
- Hospital de Câncer de Recife ( Site 0447)
-
연락하다:
- Study Coordinator
- 전화번호: +558132178084
-
-
Piauí
-
Teresina, Piauí, 브라질, 64049-200
- 완전한
- Oncoclínica Oncologistas Associados ( Site 0441)
-
-
Rio Grande do Norte
-
Natal, Rio Grande do Norte, 브라질, 59062-000
- 모병
- Liga Norte Riograndense Contra o Câncer ( Site 0439)
-
연락하다:
- Study Coordinator
- 전화번호: +558440095595
-
-
Rio Grande do Sul
-
Ijuí, Rio Grande do Sul, 브라질, 98700 000
- 모병
- Hospital de Caridade de Ijuí ( Site 0438)
-
연락하다:
- Study Coordinator
- 전화번호: +5555991221138
-
Passo Fundo, Rio Grande do Sul, 브라질, 99010-260
- 모병
- Hospital de Clínicas de Passo Fundo ( Site 0442)
-
연락하다:
- Study Coordinator
- 전화번호: +5554981271411
-
Porto Alegre, Rio Grande do Sul, 브라질, 90050-170
- 모병
- Irmandade da Santa Casa de Misericórdia de Porto Alegre-Centro Multidisciplinar de Pesquisa Clínica ( Site 0435)
-
연락하다:
- Study Coordinator
- 전화번호: +555132148143
-
-
São Paulo
-
Barretos, São Paulo, 브라질, 14784-400
- 모병
- Fundação Pio XII - Hospital de Câncer de Barretos-Unidade de Pesquisa Clínica ( Site 0437)
-
연락하다:
- Study Coordinator
- 전화번호: +551733216638
-
-
-
-
-
Barcelona, 스페인, 08035
- 모병
- Hospital Universitari Vall d Hebron ( Site 2010)
-
연락하다:
- Study Coordinator
- 전화번호: +34 932 543 450
-
Madrid, 스페인, 28040
- 모병
- Hospital Universitario Fundación Jiménez Díaz-Oncology & Hematology ( Site 2017)
-
연락하다:
- Study Coordinator
- 전화번호: 34915504800x253900
-
Madrid, 스페인, 28006
- 모병
- Hospital Universitario La Princesa ( Site 2020)
-
연락하다:
- Study Coordinator
- 전화번호: +34915202200
-
Málaga, 스페인, 29010
- 모병
- Hospital Universitario Virgen de la Victoria ( Site 2021)
-
연락하다:
- Study Coordinator
- 전화번호: 0034671594566
-
Seville, 스페인, 41009
- 모병
- Hospital Universitario Virgen Macarena-Unidad de Investigación Oncológica ( Site 2015)
-
연락하다:
- Study Coordinator
- 전화번호: 34954712941
-
-
Barcelona
-
Vic, Barcelona, 스페인, 08500
- 모병
- H. General de Vic ( Site 2022)
-
연락하다:
- Study Coordinator
- 전화번호: +34937027732
-
-
Las Palmas
-
Las Palmas de Gran Canaria, Las Palmas, 스페인, 35001
- 모병
- Hospital Insular de Gran Canaria-Oncology ( Site 2019)
-
연락하다:
- Study Coordinator
- 전화번호: +34 928441738
-
-
Madrid, Comunidad de
-
Leganés, Madrid, Comunidad de, 스페인, 28911
- 모병
- Hospital Universitario Severo Ochoa ( Site 2024)
-
연락하다:
- Study Coordinator
- 전화번호: +34914818000
-
Madrid, Madrid, Comunidad de, 스페인, 28009
- 모병
- HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON-ONCOLOGY ( Site 2012)
-
연락하다:
- Study Coordinator
- 전화번호: +34 915868115
-
-
Malaga
-
Málaga, Malaga, 스페인, 29011
- 모병
- H.R.U Málaga - Hospital General-Oncology ( Site 2014)
-
연락하다:
- Study Coordinator
- 전화번호: +34 951308130
-
-
-
-
Buenos Aires
-
Berazategui, Buenos Aires, 아르헨티나, B1884BBF
- 모병
- Centro de Oncología e Investigación de Buenos Aires ( Site 0308)
-
연락하다:
- Study Coordinator
- 전화번호: +541142262013
-
CABA, Buenos Aires, 아르헨티나, C1019ABS
- 완전한
- AUSTRAL MEDICAL CENTER ( Site 0302)
-
CABA, Buenos Aires, 아르헨티나, C1426AGE
- 모병
- Centro Oncologico Korben ( Site 0304)
-
연락하다:
- Study Coordinator
- 전화번호: 1157507952
-
Mar del Plata, Buenos Aires, 아르헨티나, B7600FZO
- 모병
- Instituto de Investigaciones Clínicas Mar del Plata ( Site 0300)
-
연락하다:
- Study Coordinator
- 전화번호: 02234963224
-
-
Río Negro Province
-
Viedma, Río Negro Province, 아르헨티나, R8500ACE
- 모병
- Clinica Viedma S. A ( Site 0307)
-
연락하다:
- Study Coordinator
- 전화번호: +54 2920 42-8700
-
-
Santa Fe Province
-
Rosario, Santa Fe Province, 아르헨티나, S2000DEJ
- 모병
- Fundacion Estudios Clinicos ( Site 0306)
-
연락하다:
- Study Coordinator
- 전화번호: +543412221472
-
Rosario, Santa Fe Province, 아르헨티나, S2000DSV
- 모병
- Sanatorio Parque ( Site 0301)
-
연락하다:
- Study Coordinator
- 전화번호: +54341420-0222
-
-
-
-
Buckinghamshire
-
Milton Keynes, Buckinghamshire, 영국, MK6 5LD
- 모병
- Milton Keynes Hospital ( Site 2304)
-
연락하다:
- Study Coordinator
- 전화번호: 01908 997609
-
-
Devon
-
Exeter, Devon, 영국, EX2 5DW
- 모병
- Royal Devon & Exeter Hospital-Oncology ( Site 2302)
-
연락하다:
- Study Coordinator
- 전화번호: +44 (0) 1392 402869
-
-
-
-
-
Vienna, 오스트리아, 1210
- 모병
- Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 2400)
-
연락하다:
- Study Coordinator
- 전화번호: 0043 1 27700 72212
-
-
Styria
-
Graz, Styria, 오스트리아, 8036
- 모병
- Medizinische Universität Graz-Klinische Abteilung für Pulmonologie ( Site 2401)
-
연락하다:
- Study Coordinator
- 전화번호: 004331638512183
-
-
-
-
Cherkasy Oblast
-
Cherkasy, Cherkasy Oblast, 우크라이나, 18009
- 완전한
- COMMUNAL NONPROFIT ENTERPRISE CLINICAL CENTER OF ONCOLOGY, HEMATOLOGY, TRANSPLANTOLOGY AND PALLIATI ( Site 2209)
-
-
Chernivetska Oblast
-
Chernivtsi, Chernivetska Oblast, 우크라이나, 58013
- 모병
- Regional Municipal Non-profit Enterprise "Bukovinian Clinical Oncology Center" ( Site 2210)
-
연락하다:
- Study Coordinator
- 전화번호: +380955077568
-
-
Dnipropetrovsk Oblast
-
Kryvyi Rih, Dnipropetrovsk Oblast, 우크라이나, 50000
- 모병
- Medical Center "Mriya Med-Service"-Clinical Research Department ( Site 2215)
-
연락하다:
- Study Coordinator
- 전화번호: +380973567855
-
-
Ivano-Frankivsk Oblast
-
Ivano-Frankivsk, Ivano-Frankivsk Oblast, 우크라이나, 76018
- 모병
- Communal Non-Commercial Enterprise "Prykarpatski Clinical On-Surgery department #2 ( Site 2202)
-
연락하다:
- Study Coordinator
- 전화번호: +380978411455
-
-
Kirovohrad Oblast
-
Kropyvnytskyi, Kirovohrad Oblast, 우크라이나, 25011
- 모병
- Kirovohrad Regional Oncology Center-Chemotherapy department ( Site 2204)
-
연락하다:
- Study Coordinator
- 전화번호: +380508412400
-
-
Kyivska Oblast
-
Kiev, Kyivska Oblast, 우크라이나, 03022
- 모병
- Medical Center "MedOffice Group" ( Site 2219)
-
연락하다:
- Study Coordinator
- 전화번호: +380503858689
-
Kyiv, Kyivska Oblast, 우크라이나, 03039
- 모병
- LLC Clinic Verum Expert ( Site 2223)
-
연락하다:
- Study Coordinator
- 전화번호: +380443835959
-
-
Lviv Oblast
-
Lviv, Lviv Oblast, 우크라이나, 79059
- 모병
- Lviv Territorial Medical Union Multidisciplinary Clinical Hospital ( Site 2217)
-
연락하다:
- Study Coordinator
- 전화번호: +380506749772
-
-
Rivne Oblast
-
Rivne, Rivne Oblast, 우크라이나, 33007
- 완전한
- Rivne Regional Clinical Hospital ( Site 2205)
-
Rivne, Rivne Oblast, 우크라이나, 33010
- 모병
- ME RIVNE REGIONAL ANTITUMOR CENTER ( Site 2920)
-
연락하다:
- Study Coordinator
- 전화번호: +380362633075
-
-
Vinnytsia Oblast
-
Vinnytsia, Vinnytsia Oblast, 우크라이나, 21029
- 모병
- Communal Noncommercial Enterprise "Podillia Regional Oncolog-Cardiothoracic department ( Site 2211)
-
연락하다:
- Study Coordinator
- 전화번호: +380953105783
-
-
Volyn Oblast
-
Lutsk, Volyn Oblast, 우크라이나, 43018
- 모병
- ME Volyn Regional Clinical Hospital of the Volyn Regional Council ( Site 2216)
-
연락하다:
- Study Coordinator
- 전화번호: +380503782998
-
-
-
-
-
Padova, 이탈리아, 35131
- 모병
- IOV - Istituto Oncologico Veneto IRCCS UOSD - Unità di ricerca clinica ( Site 1603)
-
연락하다:
- Study Coordinator
- 전화번호: +390498215649
-
-
Campania
-
Naples, Campania, 이탈리아, 80131
- 모병
- Istituto Nazionale Tumori IRCCS Fondazione Pascale-Oncologia clinica sperimentale Toraco-Polmonare ( Site 1607)
-
연락하다:
- Study Coordinator
- 전화번호: +390811777029
-
-
Emilia-Romagna
-
Ravenna, Emilia-Romagna, 이탈리아, 48121
- 모병
- Ospedale Santa Maria delle Croci ( Site 1606)
-
연락하다:
- Study Coordinator
- 전화번호: +390544285247
-
-
Friuli Venezia Giulia
-
Aviano, Friuli Venezia Giulia, 이탈리아, 33081
- 모병
- CRO-IRCCS-Clinical Oncology ( Site 1605)
-
연락하다:
- Study Coordinator
- 전화번호: +390434309464
-
-
Lazio
-
Rome, Lazio, 이탈리아, 00168
- 모병
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 1601)
-
연락하다:
- Study Coordinator
- 전화번호: 00390630156318
-
-
Lombardy
-
Milan, Lombardy, 이탈리아, 20133
- 모병
- Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1600)
-
연락하다:
- Study Coordinator
- 전화번호: +390223903829
-
Milan, Lombardy, 이탈리아, 20141
- 모병
- Istituto Europeo di Oncologia IRCCS-Divisione di Oncologia Toracica ( Site 1604)
-
연락하다:
- Study Coordinator
- 전화번호: +390257489482
-
-
Napoli
-
Naples, Napoli, 이탈리아, 80131
- 모병
- A.O.R.N. Ospedale dei Colli - Monaldi V.-U.O.C Pneumologia Oncologica DH PNL ONC ( Site 1602)
-
연락하다:
- Study Coordinator
- 전화번호: 0817062652
-
-
Roma
-
Rome, Roma, 이탈리아, 00144
- 모병
- Istituto Nazionale Tumori Regina Elena-Oncologia Medica 2 ( Site 1609)
-
연락하다:
- Study Coordinator
- 전화번호: +390652662205
-
-
Tuscany
-
Livorno, Tuscany, 이탈리아, 57124
- 모병
- Azienda USL Toscana Nord Ovest_Ospedale Civile di Livorno-UOC Oncologia Medica Livorno ( Site 1608)
-
연락하다:
- Study Coordinator
- 전화번호: 00390586223416
-
-
-
-
Maharashtra
-
Mumbai, Maharashtra, 인도, 400012
- 모병
- Tata Memorial Hospital ( Site 3205)
-
연락하다:
- Study Coordinator
- 전화번호: 02224177000
-
Mumbai, Maharashtra, 인도, 400004
- 모집하지 않고 적극적으로
- Sir H. N. Reliance Foundation Hospital and Research Centre ( Site 3201)
-
-
National Capital Territory of Delhi
-
New Delhi, National Capital Territory of Delhi, 인도, 110076
- 모병
- Indraprastha Apollo Hospitals-APOLLO RESEARCH INNOVATION ( Site 3203)
-
연락하다:
- Study Coordinator
- 전화번호: +919426166688
-
New Delhi, National Capital Territory of Delhi, 인도, 110029
- 모병
- AIIMS New Delhi Dept of Medicine ( Site 3206)
-
연락하다:
- Study Coordinator
- 전화번호: +91-9650629370
-
-
-
-
-
Chiba, 일본, 260-8677
- 모병
- Chiba University Hospital ( Site 3322)
-
연락하다:
- Study Coordinator
- 전화번호: +81-43-222-7171
-
Hiroshima, 일본, 730-8518
- 모병
- Hiroshima City Hiroshima Citizens Hospital ( Site 3314)
-
연락하다:
- Study Coordinator
- 전화번호: +81-82-221-2291
-
Kumamoto, 일본, 861-4193
- 모병
- Saiseikai Kumamoto Hospital ( Site 3318)
-
연락하다:
- Study Coordinator
- 전화번호: +81-96-351-8000
-
Niigata, 일본, 951-8520
- 모병
- Niigata University Medical & Dental Hospital ( Site 3323)
-
연락하다:
- Study Coordinator
- 전화번호: +81-25-223-6161
-
Osaka, 일본, 545-8586
- 모병
- Osaka Metropolitan University Hospital ( Site 3321)
-
연락하다:
- Study Coordinator
- 전화번호: +81-6-6645-2121
-
-
Aichi-ken
-
Nagoya, Aichi-ken, 일본, 466-8560
- 모병
- Nagoya University Hospital ( Site 3309)
-
연락하다:
- Study Coordinator
- 전화번호: +81-52-741-2111
-
Toyoake, Aichi-ken, 일본, 470-1192
- 모병
- Fujita Health University Hospital ( Site 3310)
-
연락하다:
- Study Coordinator
- 전화번호: +81-562-93-2111
-
-
Chiba
-
Kashiwa, Chiba, 일본, 277-8577
- 모병
- National Cancer Center Hospital East ( Site 3303)
-
연락하다:
- Study Coordinator
- 전화번호: +81-4-7133-1111
-
-
Ehime
-
Matsuyam, Ehime, 일본, 719-0280
- 모병
- National Hospital Organization Shikoku Cancer Center ( Site 3315)
-
연락하다:
- Study Coordinator
- 전화번호: +81-89-999-1111
-
-
Fukuoka
-
Fukuoka, Fukuoka, 일본, 811-1395
- 모병
- National Hospital Organization Kyushu Cancer Center ( Site 3316)
-
연락하다:
- Study Coordinator
- 전화번호: +81-92-541-3231
-
Kurume, Fukuoka, 일본, 830-0011
- 모병
- Kurume University Hospital ( Site 3317)
-
연락하다:
- Study Coordinator
- 전화번호: +81-942-35-3311
-
-
Gunma
-
Ōta, Gunma, 일본, 373-8550
- 모병
- Gunma Prefectural Cancer Center ( Site 3302)
-
연락하다:
- Study Coordinator
- 전화번호: +81-276-38-0771
-
-
Hokkaido
-
Sapporo, Hokkaido, 일본, 060-8543
- 모병
- Sapporo Medical University Hospital ( Site 3324)
-
연락하다:
- Study Coordinator
- 전화번호: +81-11-611-2111
-
-
Ishikawa-ken
-
Kanazawa, Ishikawa-ken, 일본, 920-8641
- 모병
- Kanazawa University Hospital ( Site 3308)
-
연락하다:
- Study Coordinator
- 전화번호: +81-76-265-2000
-
-
Kanagawa
-
Kawasaki, Kanagawa, 일본, 216-8511
- 모병
- St. Marianna University Hospital ( Site 3320)
-
연락하다:
- Study Coordinator
- 전화번호: +81-44-977-8111
-
-
Mie-ken
-
Matsusaka, Mie-ken, 일본, 515-8544
- 모병
- Saiseikai Matsusaka Municipal Hospital ( Site 3311)
-
연락하다:
- Study Coordinator
- 전화번호: +81-598-23-1515
-
-
Miyagi
-
Natori-shi, Miyagi, 일본, 981-1293
- 모병
- Miyagi Cancer Center ( Site 3301)
-
연락하다:
- Study Coordinator
- 전화번호: +81-22-384-3151
-
Sendai, Miyagi, 일본, 981-0914
- 모병
- Sendai Kousei Hospital ( Site 3300)
-
연락하다:
- Study Coordinator
- 전화번호: +81-22-222-6181
-
-
Osaka
-
Hirakata, Osaka, 일본, 573-1191
- 모병
- Kansai Medical University Hospital ( Site 3312)
-
연락하다:
- Study Coordinator
- 전화번호: +81-72-804-0101
-
Takatsuki, Osaka, 일본, 569-8686
- 모병
- Osaka Medical and Pharmaceutical University Hospital ( Site 3313)
-
연락하다:
- Study Coordinator
- 전화번호: +81-72-683-1221
-
-
Saitama
-
Kitaadachi-gun, Saitama, 일본, 362-0806
- 모병
- Saitama Prefectural Cancer Center ( Site 3304)
-
연락하다:
- Study Coordinator
- 전화번호: +81-48-722-1111
-
-
Tokyo
-
Bunkyo, Tokyo, 일본, 113-8603
- 모병
- Nippon Medical School Hospital ( Site 3306)
-
연락하다:
- Study Coordinator
- 전화번호: +81-3-3822-2131
-
Shinjuku, Tokyo, 일본, 160-0023
- 모병
- Tokyo Medical University Hospital ( Site 3307)
-
연락하다:
- Study Coordinator
- 전화번호: +81-3-3342-6111
-
Shinjuku, Tokyo, 일본, 162-8655
- 모병
- National Center for Global Health and Medicine ( Site 3305)
-
연락하다:
- Study Coordinator
- 전화번호: +81-3-3202-7181
-
Ōta-ku, Tokyo, 일본, 143-8541
- 모병
- Toho University Omori Medical Center ( Site 3319)
-
연락하다:
- Study Coordinator
- 전화번호: +81-3-3762-4151
-
-
-
-
Anhui
-
Hefei, Anhui, 중국, 230031
- 모집하지 않고 적극적으로
- Anhui Provincial Cancer Hospital ( Site 3136)
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, 중국, 100142
- 모집하지 않고 적극적으로
- Beijing Cancer hospital ( Site 3133)
-
Beijing, Beijing Municipality, 중국, 100142
- 모집하지 않고 적극적으로
- Beijing Cancer hospital ( Site 3134)
-
Beijing, Beijing Municipality, 중국, 100730
- 모집하지 않고 적극적으로
- Beijing Peking Union Medical College Hospital-pneumology department ( Site 3102)
-
Beijing, Beijing Municipality, 중국, 101149
- 모집하지 않고 적극적으로
- Beijing Chest Hospital,Capital Medical University ( Site 3104)
-
-
Chongqing Municipality
-
Chongqing, Chongqing Municipality, 중국, 400030
- 모집하지 않고 적극적으로
- Chongqing University Cancer Hospital ( Site 3119)
-
Chongqing, Chongqing Municipality, 중국, 400042
- 완전한
- Army Medical Center of People's Liberation Army ( Site 3142)
-
-
Fujian
-
Fuzhou, Fujian, 중국, 350014
- 모집하지 않고 적극적으로
- Fujian Cancer Hospital ( Site 3127)
-
Xiamen, Fujian, 중국, 361003
- 모집하지 않고 적극적으로
- The First Affiliated hospital of Xiamen University ( Site 3148)
-
-
Guangdong
-
Guangzhou, Guangdong, 중국, 510160
- 완전한
- The First Affiliated Hospital of Guangzhou Medical University ( Site 3108)
-
Guangzhou, Guangdong, 중국, 510515
- 모집하지 않고 적극적으로
- Southern Medical University Nanfang Hospital ( Site 3128)
-
Guangzhou, Guangdong, 중국, 510555
- 완전한
- Sun Yat-sen University Cancer Center ( Site 3137)
-
-
Heilongjiang
-
Harbin, Heilongjiang, 중국, 150081
- 모집하지 않고 적극적으로
- Harbin Medical University Cancer Hospital ( Site 3123)
-
Jiamusi, Heilongjiang, 중국, 154007
- 모집하지 않고 적극적으로
- JIAMUSI TUBERCULOSIS HOSPITAL(CANCER HOSPITAL) ( Site 3124)
-
-
Henan
-
Zhengzhou, Henan, 중국, 450008
- 모집하지 않고 적극적으로
- Henan Cancer Hospital ( Site 3149)
-
-
Hubei
-
Wuhan, Hubei, 중국, 430000
- 모집하지 않고 적극적으로
- Tongji Hospital Tongji Medical,Science & Technology ( Site 3113)
-
Wuhan, Hubei, 중국, 430079
- 모집하지 않고 적극적으로
- Hubei Cancer Hospital ( Site 3126)
-
-
Hunan
-
Changsha, Hunan, 중국, 410011
- 완전한
- The Second Xiangya Hospital of Central South University ( Site 3130)
-
Changsha, Hunan, 중국, 410013
- 모집하지 않고 적극적으로
- Hunan Cancer Hospital ( Site 3141)
-
-
Jiangsu
-
Nanjing, Jiangsu, 중국, 210008
- 모집하지 않고 적극적으로
- Nanjing Gulou Hospital ( Site 3122)
-
Nanjing, Jiangsu, 중국, 210012
- 완전한
- Nanjing First Hospital ( Site 3154)
-
Suzhou, Jiangsu, 중국, 215006
- 완전한
- The First Affiliated Hospital of Soochow University ( Site 3146)
-
Wuxi, Jiangsu, 중국, 214122
- 모집하지 않고 적극적으로
- Affiliated Hospital of Jiangnan University(Wuxi Fourth People's Hospital ) ( Site 3155)
-
-
Jiangxi
-
Nanchang, Jiangxi, 중국, 330000
- 완전한
- The Second Affiliated Hospital of Nanchang University ( Site 3139)
-
Nanchang, Jiangxi, 중국, 330006
- 모집하지 않고 적극적으로
- The First affiliated hospital of Nanchang University (Xianghu campus) ( Site 3138)
-
-
Jilin
-
Changchun, Jilin, 중국, 130012
- 모집하지 않고 적극적으로
- Jilin Province Tumor Hospital ( Site 3107)
-
-
Shaanxi
-
Xi'an, Shaanxi, 중국, 710000
- 완전한
- The First Affiliated Hospital of Xi'an Jiaotong University ( Site 3150)
-
-
Shandong
-
Jinan, Shandong, 중국, 250117
- 모집하지 않고 적극적으로
- Shandong Cancer Hospital ( Site 3116)
-
Linyi, Shandong, 중국, 276001
- 모집하지 않고 적극적으로
- LinYi Cancer Hospital ( Site 3111)
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, 중국, 200030
- 모집하지 않고 적극적으로
- Shanghai Chest Hospital ( Site 3100)
-
Shanghai, Shanghai Municipality, 중국, 200032
- 모집하지 않고 적극적으로
- Fudan University Shanghai Cancer Center ( Site 3144)
-
Shanghai, Shanghai Municipality, 중국, 200032
- 모집하지 않고 적극적으로
- Zhongshan Hospital,Fudan University ( Site 3143)
-
-
Shanxi
-
Taiyuan, Shanxi, 중국, 030000
- 모집하지 않고 적극적으로
- Shanxi Cancer Hospital ( Site 3131)
-
Xian, Shanxi, 중국, 710038
- 완전한
- The Second Affiliated Hospital of Air Force Medical University ( Site 3117)
-
Xian, Shanxi, 중국, 710038
- 모집하지 않고 적극적으로
- The Second Affiliated Hospital of Air Force Medical University ( Site 3152)
-
-
Sichuan
-
Chengdu, Sichuan, 중국, 610000
- 모집하지 않고 적극적으로
- West China Hospital, Sichuan University ( Site 3140)
-
Chengdu, Sichuan, 중국, 610031
- 모집하지 않고 적극적으로
- The Third People's Hospital of Chengdu (CDTPH) ( Site 3157)
-
Chengdu, Sichuan, 중국, 610042
- 모집하지 않고 적극적으로
- Sichuan Cancer hospital. ( Site 3109)
-
Neijiang, Sichuan, 중국, 641000
- 모집하지 않고 적극적으로
- The Second People's Hospital of Neijiang ( Site 3105)
-
-
Xinjiang
-
Ürümqi, Xinjiang, 중국, 830000
- 완전한
- Xinjiang Medical University Cancer Hospital - Urumqi ( Site 3101)
-
-
Yunnan
-
Kunming, Yunnan, 중국, 650107
- 모집하지 않고 적극적으로
- Yunnan Province Cancer Hospital ( Site 3153)
-
-
Zhejiang
-
Hangzhou, Zhejiang, 중국, 310006
- 모집하지 않고 적극적으로
- The first Affiliated Hospital, Zhejiang University School of Medicine ( Site 3115)
-
Hangzhou, Zhejiang, 중국, 310016
- 모집하지 않고 적극적으로
- Sir Run Run Shaw Hospital of Zhejiang University School of Medicine ( Site 3121)
-
Linhai, Zhejiang, 중국, 317000
- 모집하지 않고 적극적으로
- Taizhou Hospital of Zhejiang Province ( Site 3145)
-
Wenzhou, Zhejiang, 중국, 325015
- 모집하지 않고 적극적으로
- The First Affiliated Hospital of Wenzhou Medical University ( Site 3151)
-
-
-
-
Maule Region
-
Talca, Maule Region, 칠레, 3465584
- 모병
- Clinica Universidad Catolica del Maule-Oncology ( Site 0500)
-
연락하다:
- Study Coordinator
- 전화번호: +56947532700
-
-
Region M. de Santiago
-
Santiago, Region M. de Santiago, 칠레, 7500713
- 모병
- Orlandi Oncologia-Oncology ( Site 0503)
-
연락하다:
- Study Coordinator
- 전화번호: +56226057491
-
Santiago, Region M. de Santiago, 칠레, 7500921
- 모병
- FALP-UIDO ( Site 0501)
-
연락하다:
- Study Coordinator
- 전화번호: +56224205098
-
Santiago, Region M. de Santiago, 칠레, 8420383
- 모병
- Bradfordhill-Clinical Area ( Site 0504)
-
연락하다:
- Study Coordinator
- 전화번호: +56229490970
-
Santiago, Region M. de Santiago, 칠레, 7560913
- 모병
- Centro de Oncología de Precisión ( Site 0502)
-
연락하다:
- Study Coordinator
- 전화번호: 56991612199
-
-
-
-
Manitoba
-
Winnipeg, Manitoba, 캐나다, R3E 0V9
- 모병
- CancerCare Manitoba ( Site 0210)
-
연락하다:
- Study Coordinator
- 전화번호: 204-787-4156
-
-
Nova Scotia
-
Halifax, Nova Scotia, 캐나다, B3H 2Y9
- 모병
- QEII Health Sciences Centre - Victoria General Site-Dept. of Medical Oncology ( Site 0208)
-
연락하다:
- Study Coordinator
- 전화번호: 9024737964
-
-
Ontario
-
Hamilton, Ontario, 캐나다, L8V 5C2
- 모병
- Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0205)
-
연락하다:
- Study Coordinator
- 전화번호: 9053879495
-
Toronto, Ontario, 캐나다, M4N 3M5
- 모병
- Sunnybrook Research Institute ( Site 0206)
-
연락하다:
- Study Coordinator
- 전화번호: 4164805000x687435
-
-
Quebec
-
Montreal, Quebec, 캐나다, H3T 1M5
- 모병
- St. Marys Hospital Center ( Site 0204)
-
연락하다:
- Study Coordinator
- 전화번호: 5143453511
-
Trois-Rivières, Quebec, 캐나다, G8Z 3R9
- 모병
- Centre integre universitaire de sante et de services sociaux de la Mauricie-et-du-centre-du-quebec ( Site 0207)
-
연락하다:
- Study Coordinator
- 전화번호: 8196973333x63238
-
-
-
-
-
San José, 코스타리카, 10103
- 모병
- Onco Tech, S.A. ( Site 4102)
-
연락하다:
- Study Coordinator
- 전화번호: +50622586260
-
-
-
-
Cesar Department
-
Valledupar, Cesar Department, 콜롬비아, 200001
- 모병
- Sociedad De Oncología y Hematología Del Cesar SAS ( Site 4000)
-
연락하다:
- Study Coordinator
- 전화번호: +573122354788
-
-
Cundinamarca
-
Bogota, Cundinamarca, 콜롬비아, 110111
- 모병
- Clinica Oncologica Colsubsidio ( Site 4003)
-
연락하다:
- Study Coordinator
- 전화번호: +573142059194
-
-
Risaralda Department
-
Pereira, Risaralda Department, 콜롬비아, 660001
- 모병
- Oncologos del Occidente ( Site 4005)
-
연락하다:
- Study Coordinator
- 전화번호: +57 3187715522
-
-
Valle del Cauca Department
-
Cali, Valle del Cauca Department, 콜롬비아, 76001
- 모병
- Hemato Oncologos SA ( Site 4002)
-
연락하다:
- Study Coordinator
- 전화번호: +573167711932
-
-
-
-
-
Adana, 터키 (Türkiye), 01140
- 모병
- Adana Medical Park Seyhan Hastanesi-Medikal Onkoloji ( Site 2107)
-
연락하다:
- Study Coordinator
- 전화번호: +90 322 456 19 00
-
Ankara, 터키 (Türkiye), 06010
- 모병
- SBU GULHANE EGITIM VE ARASTIRMA HASTANESI Onkoloji ( Site 2104)
-
연락하다:
- Study Coordinator
- 전화번호: +905058726378
-
Ankara, 터키 (Türkiye), 06230
- 모병
- Hacettepe Universite Hastaneleri-oncology hospital ( Site 2101)
-
연락하다:
- Study Coordinator
- 전화번호: +90 312 305 10 80
-
Ankara, 터키 (Türkiye), 06520
- 모병
- Memorial Ankara Hastanesi-Medical Oncology ( Site 2106)
-
연락하다:
- Study Coordinator
- 전화번호: +903122536666
-
Ankara, 터키 (Türkiye), 06800
- 모병
- Ankara Bilkent Şehir Hastanesi ( Site 2100)
-
연락하다:
- Study Coordinator
- 전화번호: +903125526000
-
Istanbul, 터키 (Türkiye), 34214
- 모병
- Medipol Mega Universite Hastanesi-oncology ( Site 2105)
-
연락하다:
- Study Coordinator
- 전화번호: +902124447044
-
Istanbul, 터키 (Türkiye), 34722
- 모병
- TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 2103)
-
연락하다:
- Study Coordinator
- 전화번호: +902166065200
-
Sakarya, 터키 (Türkiye), 54290
- 모병
- Sakarya Training and Research Hospital ( Site 2109)
-
연락하다:
- Study Coordinator
- 전화번호: +902648884000
-
-
İzmir
-
Balçova, İzmir, 터키 (Türkiye), 35340
- 모병
- Dokuz Eylul Universitesi Hastanesi ( Site 2108)
-
연락하다:
- Study Coordinator
- 전화번호: +902323434343
-
Bornova, İzmir, 터키 (Türkiye), 35100
- 모병
- Ege Universitesi Hastanesi-Chest Diseases Department ( Site 2102)
-
연락하다:
- Study Coordinator
- 전화번호: +905322202675
-
-
-
-
-
Lima, 페루, 15036
- 모병
- IPOR Instituto Peruano de Oncología & Radioterapia ( Site 4301)
-
연락하다:
- Study Coordinator
- 전화번호: 511 2241598 anex 121
-
-
-
-
Lesser Poland Voivodeship
-
Gorlice, Lesser Poland Voivodeship, 폴란드, 38-300
- 완전한
- Szpital Specjalistyczny im. Henryka Klimontowicza ( Site 1801)
-
Krakow, Lesser Poland Voivodeship, 폴란드, 30-727
- 완전한
- Pratia MCM Krakow ( Site 1808)
-
-
Lublin Voivodeship
-
Lublin, Lublin Voivodeship, 폴란드, 20-090
- 모병
- Uniwersytecki Szpital Kliniczny nr 4 w Lublinie ( Site 1805)
-
연락하다:
- Study Coordinator
- 전화번호: +48 814485180
-
-
Masovian Voivodeship
-
Warsaw, Masovian Voivodeship, 폴란드, 02-781
- 모병
- Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 1800)
-
연락하다:
- Study Coordinator
- 전화번호: +48225462336
-
-
Podkarpackie Voivodeship
-
Przemyśl, Podkarpackie Voivodeship, 폴란드, 37-700
- 모병
- Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 1804)
-
연락하다:
- Study Coordinator
- 전화번호: +48166775000
-
-
Warmian-Masurian Voivodeship
-
Olsztyn, Warmian-Masurian Voivodeship, 폴란드, 10-357
- 모병
- Warminsko-Mazurskie Centrum Chorob Pluc w Olsztynie ( Site 1809)
-
연락하다:
- Study Coordinator
- 전화번호: +48895322978
-
-
-
-
Alpes-Maritimes
-
Nice, Alpes-Maritimes, 프랑스, 06000
- 모병
- Centre Hospitalier Universitaire de Nice - Hopital Pasteur ( Site 1108)
-
연락하다:
- Study Coordinator
- 전화번호: +33492038281
-
-
Bourgogne-Franche-Comté
-
Dijon, Bourgogne-Franche-Comté, 프랑스, 21000
- 모병
- Centre Hospitalier Universitaire Dijon Bourgogne - Hôpital François Mitterrand ( Site 1103)
-
연락하다:
- Study Coordinator
- 전화번호: +33380293772
-
-
Gard
-
Nîmes, Gard, 프랑스, 30029
- 모병
- Centre Hospitalier Universitaire de Nîmes - Institut de Cancérologie du Gard - Hôpital Universitaire ( Site 1106)
-
연락하다:
- Study Coordinator
- 전화번호: +33 4 66 68 32 21
-
-
Nord
-
Valenciennes, Nord, 프랑스, 59304
- 모병
- Clinique Teissier Groupe ( Site 1100)
-
연락하다:
- Study Coordinator
- 전화번호: +33327142337
-
-
Puy-de-Dome
-
Clermont-Ferrand, Puy-de-Dome, 프랑스, 63003
- 모병
- Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne-ONCOLOGY ( Site 1101)
-
연락하다:
- Study Coordinator
- 전화번호: +33473278005
-
-
Vaucluse
-
Avignon, Vaucluse, 프랑스, 84000
- 모병
- Centre Hospitalier d'Avignon-Service d'Oncologie médicale et d'hématologie clinique ( Site 1104)
-
연락하다:
- Study Coordinator
- 전화번호: +33432753333
-
-
Île-de-France Region
-
Boulogne-Billancourt, Île-de-France Region, 프랑스, 92100
- 모병
- Hôpital Ambroise Paré-Department of Respiratory Diseases and Thoracic Oncology ( Site 1105)
-
연락하다:
- Study Coordinator
- 전화번호: +33149095806
-
-
-
-
National Capital Region
-
Pasig, National Capital Region, 필리핀 제도, 1600
- 모병
- The Medical City ( Site 3507)
-
연락하다:
- Study Coordinator
- 전화번호: (02)6356789 loc 5083
-
Quezon City, National Capital Region, 필리핀 제도, 1100
- 모병
- Lung Center of the Philippines-Pulmonary, Critical Care and Sleep Medicine ( Site 3503)
-
연락하다:
- Study Coordinator
- 전화번호: +632 892 46101*1309
-
Quezon City, National Capital Region, 필리핀 제도, 1102
- 모병
- ST. LUKE'S MEDICAL CENTER-Medical oncology ( Site 3501)
-
연락하다:
- Study Coordinator
- 전화번호: +63287230101
-
Quezon City, National Capital Region, 필리핀 제도, 1100
- 모집하지 않고 적극적으로
- Veterans Memorial Medical Center-Section of Oncology ( Site 3505)
-
-
-
-
New South Wales
-
Camperdown, New South Wales, 호주, 2050
- 모병
- Chris O'Brien Lifehouse ( Site 3000)
-
연락하다:
- Study Coordinator
- 전화번호: +61285140140
-
-
Queensland
-
Urraween, Queensland, 호주, 4655
- 모병
- Cancer Care Service Hervey Bay ( Site 3003)
-
연락하다:
- Study Coordinator
- 전화번호: +610743256110
-
-
Victoria
-
Frankston, Victoria, 호주, 3199
- 모병
- Frankston Hospital ( Site 3002)
-
연락하다:
- Study Coordinator
- 전화번호: +61397847777
-
-
Western Australia
-
Nedlands, Western Australia, 호주, 6009
- 모병
- One Clinical Research ( Site 3001)
-
연락하다:
- Study Coordinator
- 전화번호: +61862799466
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
The main inclusion and exclusion criteria include but are not limited to the following:
Inclusion Criteria:
- Has histologically or cytologically confirmed diagnosis of non-small cell lung cancer (NSCLC)
- Has newly diagnosed Stage IIIB/IIIC NSCLC, not eligible for curative resection or curative chemotherapy/radiation as determined by a multidisciplinary tumor board and/or by radiation oncologist, surgeon, and medical oncologist or Stage IV (M1a, M1b, or M1c) by American Joint Committee on Cancer (AJCC) Staging Manual, Version 8
- Provides an archival tumor sample (≤5 years) or newly obtained core, incisional, or excisional biopsy or fine needle aspirate (FNA) of a tumor lesion, not previously irradiated to enable central laboratory testing of kirsten rat sarcoma (KRAS) G12C mutation status, programmed cell death ligand 1 (PD-L1) status, and biomarker research
- If have had adverse events (AEs) due to previous anticancer therapies, must have recovered to < Grade 1 or baseline
- If human immunodeficiency virus (HIV)-infected, must have well controlled HIV on antiretroviral therapy (ART)
- If Hepatitis B surface antigen (HBsAg) positive, have received Hepatitis B Virus (HBV) antiviral therapy for at least 4 weeks, and have undetectable HBV viral load
- If a participant has a history of Hepatitis C virus (HCV) infection, HCV viral load is undetectable
Exclusion Criteria:
- Has diagnosis of small cell lung cancer. For mixed tumors, if small cell elements are present, the participant is ineligible
- Has active inflammatory bowel disease requiring immunosuppressive medication or previous clear history of inflammatory bowel disease
- Has known history of, or active, neurologic paraneoplastic syndrome
- Has an active infection requiring systemic therapy, with exceptions
- Has uncontrolled, significant cardiovascular disease or cerebrovascular disease
- Has received prior systemic anticancer therapy for their locally advanced or metastatic NSCLC
- Has received radiation therapy to the lung that is >30 Gray within 6 months of start of study intervention
- Has received radiotherapy to non-central nervous system (CNS) disease within 2 weeks of start of study intervention. Participants must have recovered from all radiation-related toxicities, not required corticosteroids, and not have had radiation pneumonitis
- Has known active CNS metastases and/or carcinomatous meningitis
- Known additional malignancy that is progressing or has required active treatment within the past 3 years
- Has active autoimmune disease that has required systemic treatment in the past 2 years
- Has history of (noninfectious) pneumonitis/interstitial lung disease that required steroids or has current pneumonitis/interstitial lung disease
- Is HIV-infected and has a history of Kaposi's sarcoma and/or Multicentric Castleman's Disease
- Has history of allogenic tissue/solid organ transplant
- Has not fully recovered from any effects of major surgical procedure
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 삼루타
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Calderasib with Pembrolizumab
Participants receive pembrolizumab 200 mg via intravenous (IV) infusion on Day 1 of each 21-day cycle (q3w) for up to 35 cycles and calderasib by oral tablets until discontinuation criterion is met. |
IV infusion
다른 이름들:
Oral tablets
다른 이름들:
|
|
활성 비교기: Placebo with Pembrolizumab
Participants receive pembrolizumab 200 mg via intravenous (IV) infusion on Day 1 of each 21-day cycle (q3w) for up to 35 cycles and placebo by oral tablets once daily until discontinuation criterion is met. |
IV infusion
다른 이름들:
Oral tablets |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Progression-Free Survival (PFS)
기간: Up to approximately 42 months
|
PFS is defined as the time from randomization until either documented disease progression per Response Criteria in Solid Tumors Version 1.1 (RECIST 1.1) or death due to any cause, whichever occurs first. PFS as determined by blinded independent central review (BICR) will be presented. |
Up to approximately 42 months
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Overall Survival
기간: Up to approximately 57 months
|
OS is defined as the time from randomization to death due to any cause. |
Up to approximately 57 months
|
|
Objective Response Rate (ORR)
기간: Up to approximately 42 months
|
ORR is defined as the percentage of participants with Complete Response or Partial Response per RECIST1.1. The percentage of participants who experience CR or PR as assessed by BICR will be presented. |
Up to approximately 42 months
|
|
Duration of Response (DOR)
기간: Up to approximately 42 months
|
For participants who demonstrate confirmed CR or PR per RECIST 1.1 as assessed by BICR, duration of response is defined as the time from the first documented evidence of CR or PR until disease progression or death due to any cause, whichever occurs first. |
Up to approximately 42 months
|
|
Number of Participants Who Experience One or More Adverse Event (AEs)
기간: Up to approximately 80 months
|
An AE is any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening of a preexisting condition that is temporally associated with the use of the Sponsor's product, is also an AE. The number of participants who experience an AE will be presented. |
Up to approximately 80 months
|
|
Number of Participants Who Discontinue Study Treatment Due to an Adverse Event (AE)
기간: Up to approximately 80 months
|
An AE is any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening of a preexisting condition that is temporally associated with the use of the Sponsor's product, is also an AE. The number of participants who discontinue study treatment due to an AE will be presented. |
Up to approximately 80 months
|
|
Change From Baseline in European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) Global Health Status (Item 29) and Quality of Life (Item 30) Combined Score
기간: Baseline and Up to approximately 24 months
|
The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to the questions "How would you rate your overall health during the past week?" and "How would you rate your overall quality of life during the past week?" are scored on a 7-point scale (1= Very poor to 7=Excellent). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The change from baseline in the score of EORTC QLQ-C30 Items 29 and 30 will be presented. Higher scores indicate a better overall health status. |
Baseline and Up to approximately 24 months
|
|
Change From Baseline in EORTC QLQ-C30 Physical Functioning (Items 1-5) Score
기간: Baseline and Up to approximately 24 months
|
The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to 5 questions about their physical functioning are scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C30 Items 1-5 will be presented. Higher scores indicate a better level of functioning. |
Baseline and Up to approximately 24 months
|
|
Change From Baseline in EORTC QLQ-C30 Role Functioning (Items 6-7) Score
기간: Baseline and Up to approximately 24 months
|
The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to 2 questions about their role functioning are scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C30 Items 6-7 will be presented. Higher scores indicate a better level of functioning. |
Baseline and Up to approximately 24 months
|
|
Change From Baseline in EORTC QLQ-C30 Dyspnea (Item 8) Score
기간: Baseline and Up to approximately 24 months
|
The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant response to the question "Were you short of breath?" is scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C30 Item 8 will be presented. A higher score indicates a worse level of dyspnea. |
Baseline and Up to approximately 24 months
|
|
Change From Baseline in European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Lung Cancer Module (EORTC QLQ-LC13) Cough (Item 31) Score
기간: Baseline and Up to approximately 24 months
|
The EORTC QLQ-C13 is a lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant response to the question "Have you coughed?" is scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C13 Item 31 will be presented. A higher score indicates more frequent coughing. |
Baseline and Up to approximately 24 months
|
|
Change From Baseline in EORTC QLQ-LC13 Chest Pain (Item 40) Score
기간: Baseline and Up to approximately 24 months
|
The EORTC QLQ-C13 is lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant response to the question "Have you had pain in your chest?" is scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C13 Item 40 will be presented. A higher score indicates a worse level of chest pain. |
Baseline and Up to approximately 24 months
|
|
Time to Deterioration (TTD) in EORTC-QLQ-C30 Global Health Status (Item 29) Quality of Life (Item 30) Combined Score
기간: Baseline and Up to approximately 24 months
|
TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in global health status (GHS) and quality of life (QoL) (EORTC QLQ-C30 Items 29 and 30) score. Participant responses to the questions "How would you rate your overall health during the past week?" and "How would you rate your overall quality of life during the past week?" are scored on a 7-point scale (1= Very poor to 7=Excellent). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in GHS and QoL, will be presented. A longer TTD indicates a better outcome. |
Baseline and Up to approximately 24 months
|
|
TTD in EORTC-QLQ-C30 Physical Functioning (Items 1-5) Score
기간: Baseline and Up to approximately 24 months
|
TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in physical functioning (EORTC QLQ-C30 Items 1-5) score. The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to 5 questions about their physical functioning are scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in physical functioning score, will be presented. A longer TTD indicates a better outcome. |
Baseline and Up to approximately 24 months
|
|
TTD in EORTC-QLQ-C30 Role Functioning (Items 6-7) Score
기간: Baseline and Up to approximately 24 months
|
TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in role functioning (EORTC QLQ-C30 Items 6 and 7) score. The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to 2 questions about their role functioning are scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in role functioning score, will be presented. A longer TTD indicates a better outcome. |
Baseline and Up to approximately 24 months
|
|
TTD in EORTC-QLQ-C30 Dyspnea (Item 8) Score
기간: Baseline and Up to approximately 24 months
|
TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in dyspnea (EORTC QLQ-C30 Item 8) score. The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant response to the question "Were you short of breath?" is scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in dyspnea score, will be presented. A longer TTD indicates a better outcome. |
Baseline and Up to approximately 24 months
|
|
TTD in EORTC QLQ-LC13 Cough (Item 31) Score
기간: Baseline and Up to approximately 24 months
|
TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in cough (EORTC QLQ-C13 Item 31) score. The EORTC QLQ-C13 is lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant response to the question "Have you coughed?" is scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in cough score, will be presented. A longer TTD indicates a better outcome. |
Baseline and Up to approximately 24 months
|
|
TTD in EORTC QLQ-LC13 Chest Pain (Item 40) Score
기간: Baseline and Up to approximately 24 months
|
TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in chest pain (EORTC QLQ-C13 Item 40) score. The EORTC QLQ-C13 is lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant response to the question "Have you had pain in your chest?" is scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline chest pain score, will be presented. A longer TTD indicates a better outcome. |
Baseline and Up to approximately 24 months
|
공동 작업자 및 조사자
수사관
- 연구 책임자: Medical Director, Merck Sharp & Dohme LLC
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
키워드
추가 관련 MeSH 약관
기타 연구 ID 번호
- 1084-004
- MK-1084-004 (기타 식별자: MSD)
- U1111-1296-8093 (레지스트리 식별자: UTN)
- jRCT2031240213 (레지스트리 식별자: jRCT)
- PHRR241128-007796 (레지스트리 식별자: PHRR)
- 2023-507776-42-00 (레지스트리 식별자: EU CT)
- KANDLELIT-004 (기타 식별자: MSD)
- 2023 (미국 NIH 보조금/계약)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
https://trialstransparency.msdclinicaltrials.com/pdf/ProcedureAccessClinicalTrialData.pdf
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .